iPLATO Patient Care Messaging Reaches 10 Million Patients in England

iPLATOiPLATO the UK's leader in Health Tech announces today that its flagship GP service, iPLATO Patient Care Messaging now reaches more than 10 million patients through over 1,000 GP practices in England. iPLATO Patient Care Messaging allows practices to set up automated appointment reminders and to run high performance mobile patient engagement using text messaging as its primary communication channel.

A first version launched in 2006 iPLATO Patient Care Messaging has been now been adopted by 1 in 8 of GP practices in England. The rate of adoption has increased rapidly over the past 3 months with and an additional seven Clinical Commissioning Groups from the North West of England to Bexley in the South East are expanding their iPLATO Patient Care Messaging services to cover their entire populations adding 170 GP practices covering some 1.2 million patients to the iPLATO network.

Clinical Commissioning Groups sign up to iPLATO for a range of reasons:

  • iPLATO Patient Care Messaging freed up 300,000 urgent GP appointments in 2014. With a larger user base this number will increase significantly in 2015 allowing more patients to be seen in primary care and reducing the burden on local A&E. No other Health Tech provider brings benefits of this scale to the health service.
  • iPLATO Patient Care Messaging is independent of NHSmail SMS. Centrally funded text messaging on the internal NHS e-mail system is being abolished in 2015. CCGs and GP practices are seeking an experienced partner to continue popular text messaging services.
  • iPLATO is the only organisation in the UK which has successfully launched text messaging services across more than 50 PCT/CCGs. Through a tested change process the iPLATO team is able to bring the diverse population that work in GP practices to adopt new ways of communicating with patients.

Commenting, Tobias Alpsten, Chief Executive Officer of iPLATO said: "We have seen an accelerated uptake of the Patient Care Messaging service so far in 2015. While this growth is set to increase further in England in Q2 and Q3 due to the abolition of NHSmail SMS we are also seeing growing interest from Wales, Scotland and Northern Ireland. In times of rapid change it is reasonable that NHS organisations seek to partner with the most experienced organisation which offers the broadest and best product portfolio. For mobile communication in British primary care, this organisation happens to be iPLATO."

Related news articles:

About iPLATO
iPLATO Healthcare is British innovation company dedicated to mHealth and Analytics since 2006.

iPLATO's evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.

Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and pandemic awareness as well as mobile disease management services for people with diabetes, hypertension, epilepsy and HIV.

iPLATO Healthcare's mission is to, in partnership with clinicians, help healthcare commissioners transform patient care through cloud based mHealth and Analytics.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...